1999 Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

Volume 3, 1999 Archive
Six back issues from 1999 on one convenient archive.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $200.00

(Select Format)

This archive contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 3 No. 1	January/February 1999	Dental Compounding
Vol. 3 No. 2	March/April 1999	Compounding for Men's Health
Vol. 3 No. 3	May/June 1999	Compounding for Animals
Vol. 3 No. 4	July/August 1999	Compounding Parenteral Products
Vol. 3 No. 5	September/October 1999	Natural Hormone Replacement Therapy
Vol. 3 No. 6	November/December 1999	Compounding for Arthritis Patients

Volume 3, 1999 Articles

Title (Click for Details)	Vol/Issue	Page

Volume 3, 1999 Articles
Issues and Opportunities: Compounding for Dentistry	Vol. 3 No. 1	4
Compounding Mouthwashes and Rinses for Oral Ulcerations	Vol. 3 No. 1	8
Oral Ulceration Mouthwash	Vol. 3 No. 1	10
Mouthwash, Toothpaste and Toothgel Vehicles	Vol. 3 No. 1	12
Mouthwash/Gargle Formulation No. 1	Vol. 3 No. 1	12
Mouthwash/Gargle Formulation No. 2	Vol. 3 No. 1	12
Mouthwash/Gargle Formulation No. 3	Vol. 3 No. 1	12
Toothgel Vehicle	Vol. 3 No. 1	13
Toothpaste Vehicle	Vol. 3 No. 1	13
Toxicity of Amalgams	Vol. 3 No. 1	14
A Brief Look at the History of Oral Hygiene	Vol. 3 No. 1	17
Dental Compounding in Denmark	Vol. 3 No. 1	18
The Basics of Compounding: Compounding Ointments and Pastes	Vol. 3 No. 1	22
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns	Vol. 3 No. 1	25
Coenzyme Q10: It's Everywhere	Vol. 3 No. 1	30
Ubidicarenone (Coenzyme Q10) 200-mg Gelatin Troche	Vol. 3 No. 1	32
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor	Vol. 3 No. 1	34
Audit Problems for Compounding Pharmacies	Vol. 3 No. 1	36
HRT Marketing Tip	Vol. 3 No. 1	37
Ringworms in Cats	Vol. 3 No. 1	38
Profile of a Practice	Vol. 3 No. 1	39
Dental Cavity Varnish	Vol. 3 No. 1	42
Dental Chemical Curettage Agent	Vol. 3 No. 1	43
Dental Pressure Indicating Paste (PIP)	Vol. 3 No. 1	44
Fluoride Lozenges	Vol. 3 No. 1	45
Gag Tablet	Vol. 3 No. 1	46
Gum Massage Gel	Vol. 3 No. 1	47
Misoprostol 0.0024% and Lidocaine 1% in Glycerin Mouth Paint	Vol. 3 No. 1	48
Misoprostol Mucoadhesive Anesthetic Powder	Vol. 3 No. 1	49
Potassium Nitrate Desensitizing Gel	Vol. 3 No. 1	50
Tetracycline 2.4% or Metronidazole 10% Periodontal Gel	Vol. 3 No. 1	51
Antioxidants, Featured Excipient:	Vol. 3 No. 1	52
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks	Vol. 3 No. 1	56
Calculations	Vol. 3 No. 1	58
Stability of Four Commercial Products Delivered by Mail Order	Vol. 3 No. 1	59
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital	Vol. 3 No. 1	64
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature	Vol. 3 No. 1	67
Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis	Vol. 3 No. 2	76
Male Impotency and the Compounding Pharmacist	Vol. 3 No. 2	80
Medication Combinations for Penile Injections	Vol. 3 No. 2	81
Complementary Medical Approaches to Benign Prostatic Hyperplasia	Vol. 3 No. 2	85
Natural Testosterone: Hormone of the Heart	Vol. 3 No. 2	88
Use of Saw Palmetto and Pygeum in Men	Vol. 3 No. 2	99
Case Report: Testosterone Supplementation in a Vasectomy Patient	Vol. 3 No. 2	101
An Aftershave Lotion for Pseudofolliculitis Barbae	Vol. 3 No. 2	102
Compounding for Athletes: A Primer for Rookies	Vol. 3 No. 2	104
Book Reviews	Vol. 3 No. 2	107
Natural HRT: Corrective Measures When the System Goes Down	Vol. 3 No. 2	109
The Basics of Compounding: Compounding Creams and Lotions	Vol. 3 No. 2	111
Profile of a Practice	Vol. 3 No. 2	116
Tips for Collecting Mortars and Pestles	Vol. 3 No. 2	118
Personal Computing: Take Care When Choosing a Computer Consultant	Vol. 3 No. 2	122
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices	Vol. 3 No. 2	126
Marketing Tip: Locator Maps	Vol. 3 No. 2	127
Athletic-Analgesic Rub	Vol. 3 No. 2	130
Dehydroepiandrosterone 50-mg Capsules	Vol. 3 No. 2	131
Minoxidil 3% and Finasteride 0.1% Topical Liquid	Vol. 3 No. 2	132
Piroxicam 0.5% in Pluronic Lecithin Organogel	Vol. 3 No. 2	133
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection	Vol. 3 No. 2	134
Sildenafil Citrate 25-mg Sublingual Troches	Vol. 3 No. 2	135
Special Aftershave Preparations	Vol. 3 No. 2	136
Testosterone-Menthol Eutectic Ointment (2% Testosterone)	Vol. 3 No. 2	137
Testosterone 10-mg Troches	Vol. 3 No. 2	138
Testosterone 10-mg/0.1-mL Sublingual Drops	Vol. 3 No. 2	139
Preservatives, Featured Excipient:	Vol. 3 No. 2	142
Calculations	Vol. 3 No. 2	145
Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids	Vol. 3 No. 2	146
Analysis of Extemporaneous Alprostadil Formulations	Vol. 3 No. 2	148
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags	Vol. 3 No. 2	156
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography	Vol. 3 No. 2	158
In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1	Vol. 3 No. 2	160
Compounding and the Specialty Veterinary Practice: An Interview with Gary Riggs, DVM, ABVP	Vol. 3 No. 3	172
Call of the Wild: Compounding for Zoos and Exotics	Vol. 3 No. 3	176
Improving Profitability with Veterinary Compounding	Vol. 3 No. 3	180
Compounding for Creatures: What Works	Vol. 3 No. 3	182
The Top Ten Veterinary Compound Preparations	Vol. 3 No. 3	183
Veterinary Flavor Suggestions	Vol. 3 No. 3	186
When is Compounding for Animals Legal?	Vol. 3 No. 3	188
Use of Fenbendazole in Treating Trichuriasis in Colobus Monkeys	Vol. 3 No. 3	193
Returning to our Roots	Vol. 3 No. 3	194
Value and Pricing: Figuring Out What You're Worth	Vol. 3 No. 3	197
Marketing Tip: Teachable Moments: A Simple Concept	Vol. 3 No. 3	199
The BPS Pharmacy Specialty Certification Program	Vol. 3 No. 3	200
Compounding for Athletes: Tips for Making the Team	Vol. 3 No. 3	206
The Basics of Compounding: Compounding Powder-Filled Capsules	Vol. 3 No. 3	209
Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill	Vol. 3 No. 3	215
Amitriptyline HCl 1-mg/mL Oral Liquid and Gel	Vol. 3 No. 3	218
Buspirone HCl 2.5-mg/0.1-mL in PLO for Cats	Vol. 3 No. 3	219
General Sulfonamide 150-mg/mL Suspension	Vol. 3 No. 3	220
Nonaqueous Nonoleaginous Paste Base	Vol. 3 No. 3	221
Phenylpropanolamine HCl 10-mg Chewable Troches for Dogs	Vol. 3 No. 3	222
Progesterone 100-mg/mL Veterinary Injection	Vol. 3 No. 3	223
Sulfadiazine Sodium 333-mg/mL and Pyrimethamine 16.7-mg/mL Oral Liquid	Vol. 3 No. 3	224
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop	Vol. 3 No. 3	225
Veterinary Electrolyte Injection	Vol. 3 No. 3	226
Veterinary Phenobarbital 22-mg/mL Oral Liquid	Vol. 3 No. 3	227
Sweetening Agents, Featured Excipient:	Vol. 3 No. 3	228
Standard Operating Procedure for Quality Assessment of Powder-Filled, Hard-Gelatin Capsules	Vol. 3 No. 3	232
Calculations	Vol. 3 No. 3	234
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride	Vol. 3 No. 3	235
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography	Vol. 3 No. 3	239
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration	Vol. 3 No. 3	241
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding	Vol. 3 No. 4	253
Green IV Nutritionals	Vol. 3 No. 4	260
Sterilization and Depyrogenation Principles and Methods	Vol. 3 No. 4	263
Book Review-The CIVAS Handbook	Vol. 3 No. 4	269
Sterile Product Compounding: A Comparison of ASHP and USP Guidelines	Vol. 3 No. 4	270
Extemporaneous Formulations in Pediatric Patients	Vol. 3 No. 4	274
Marketing Tip: PR Can Help with Image Change and Geographic Expansion	Vol. 3 No. 4	277
Antique Pharmaceutical Balances	Vol. 3 No. 4	280
Compounding for Athletes: Common Questions about Sports Medicine	Vol. 3 No. 4	285
Profile of a Practice	Vol. 3 No. 4	288
The Basics of Compounding: Compounding Special Capsules	Vol. 3 No. 4	291
Capsules with Liquid Fill-Sample-Progesterone 100-mg	Vol. 3 No. 4	294
Capsules with Semisolid Fill-Sample-Tri-Est	Vol. 3 No. 4	294
Calcium Levulinate 15-mg/mL Injection	Vol. 3 No. 4	298
Dextrose 20% and Sodium Chloride 20% Sclerosing Injection	Vol. 3 No. 4	299
Estradiol 5-mg/mL-in-Oil Injection	Vol. 3 No. 4	300
Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration	Vol. 3 No. 4	301
Morphine Sulfate 50-mg/mL Injection	Vol. 3 No. 4	302
Parenteral Admixture with Y-Site Administration	Vol. 3 No. 4	303
Tri-Est 2.5-mg/mL Aqueous Injection	Vol. 3 No. 4	304
Trimethoprim 50-mg/mL Injection	Vol. 3 No. 4	305
Vancomycin and Ceftazidime in Peritoneal Dialysis Solution	Vol. 3 No. 4	306
Veterinary Prochlorperazine and Isopropamide Injection	Vol. 3 No. 4	307
Acidifying Agents, Featured Excipient:	Vol. 3 No. 4	309
Calculations	Vol. 3 No. 4	311
Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules	Vol. 3 No. 4	312
Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography	Vol. 3 No. 4	314
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution	Vol. 3 No. 4	316
Rapid Pharmacokinetic Evaluation of Topical Drug Formulations	Vol. 3 No. 4	321
Interview: Katharina Dalton, MD: Progesterone and Related Topics	Vol. 3 No. 5	332
Finding the Balance	Vol. 3 No. 5	340
Top Ten HRT Compound Preparations	Vol. 3 No. 5	342
Wilson's Syndrome and T3 Therapy	Vol. 3 No. 5	344
Assessment and Management of Thermoregulation	Vol. 3 No. 5	350
Case Reports: Long-Term Effects of Topical Progesterone Cream Application; Progesterone Suppositories for PMS	Vol. 3 No. 5	352
Andropause: Annotated Citations from the Literature	Vol. 3 No. 5	355
Women's Health Book Reviews	Vol. 3 No. 5	357
Planning and Marketing a Natural HRT Patient Seminar	Vol. 3 No. 5	360
Marketing Tip: Collaboration Can Result in More Cost-Effective Seminars	Vol. 3 No. 5	362
Preventing Leakage in Oil-Filled Capsules	Vol. 3 No. 5	364
Feline Urologic Syndrome and Diet Formulation	Vol. 3 No. 5	366
Compounding Practice Structures	Vol. 3 No. 5	368
Closing in on 2000: Your Y2K Report	Vol. 3 No. 5	371
Chemical Facial Peel Formulations: an Overview	Vol. 3 No. 5	375
Jessner's Solution	Vol. 3 No. 5	375
Unna's Paste	Vol. 3 No. 5	375
Baker-Gordon Formula	Vol. 3 No. 5	376
Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids	Vol. 3 No. 5	380
Tamoxifen Citrate Cream 0.1%	Vol. 3 No. 5	381
Compounding for Athletes: Successful Sports Compounds	Vol. 3 No. 5	382
The Basics of Compounding: Compounding Gels	Vol. 3 No. 5	385
Lubricating Jelly Formula	Vol. 3 No. 5	388
Poloxamer Gel Base	Vol. 3 No. 5	388
Clear Carbomer Gel	Vol. 3 No. 5	388
Piroxicam 0.5% in an Alcoholic Gel	Vol. 3 No. 5	389
Methylcellulose Gels	Vol. 3 No. 5	389
Pluronic Lecithin Organogel (PLO Gel)	Vol. 3 No. 5	389
Estriol 0.2-mg/mL in Pluronic Lecithin Organogel	Vol. 3 No. 5	392
Ethinyl Estradiol 0.2-mg Gelatin Troches	Vol. 3 No. 5	393
Progesterone 50-mg/mL Topical Gel	Vol. 3 No. 5	394
Progesterone 100-mg/mL Sublingual Drops	Vol. 3 No. 5	395
Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules	Vol. 3 No. 5	396
Progesterone 10% Topical Cream	Vol. 3 No. 5	397
Progesterone 200-mg/mL in Pluronic Lecithin Organogel	Vol. 3 No. 5	398
Testosterone 1-mg Buccal Troches	Vol. 3 No. 5	399
Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules	Vol. 3 No. 5	400
Triple Estrogen 2.5-mg Slow-Release Capsules	Vol. 3 No. 5	401
Alkalizing Agents, Featured Excipient:	Vol. 3 No. 5	404
Standard Operating Procedure: Quality Assessment for Injectable Solutions	Vol. 3 No. 5	406
Calculations	Vol. 3 No. 5	408
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules	Vol. 3 No. 5	409
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C	Vol. 3 No. 5	412
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II	Vol. 3 No. 5	415
Erratum: Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets (IJPC 1997:1(1):60-64)	Vol. 3 No. 6	427
Prescription- New Cures for Arthritis.pdf	Vol. 3 No. 6	427
Glucosamine Sulfate: A Review of Efficacy for the Pharmacy Professional	Vol. 3 No. 6	428
Osteoarthritis: Other Options	Vol. 3 No. 6	433
Book Reviews: Maximizing the Arthritis Cure: A Step-by-Step Program To Faster, Stronger Healing During Any Stage of the Cure	Vol. 3 No. 6	438
Book Reviews: The Arthritis Cure: The Medical Miracle that Can Halt, Reverse, and May Even Cure Osteoarthritis	Vol. 3 No. 6	438
Electronically Controlled Drug Delivery	Vol. 3 No. 6	439
Case Report: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player	Vol. 3 No. 6	441
Case Reports: Iontophoresis and Phonophoresis for Treating Epicondylitis	Vol. 3 No. 6	441
Compounding Radiolabeled Blood Cells for Diagnostic Imaging	Vol. 3 No. 6	443
Extemporaneous Formulations: How to Evaluate HPLC Stability Studies	Vol. 3 No. 6	447
Marketing Tip: Flavors: Target Marketing to Doctors and Patients	Vol. 3 No. 6	454
Book Reviews: Hatherleigh Guide to Psychopharmacology	Vol. 3 No. 6	454
Book Reviews: Medical Abbreviations: 14,000 Conveniences at the Expense of Communications and Safety	Vol. 3 No. 6	454
Profile of a Practice: Going the Extra Mile with Pharmaceutical Care	Vol. 3 No. 6	455
Independent Pharmacists Score High with Consumers	Vol. 3 No. 6	457
When Problem Audits Strike	Vol. 3 No. 6	458
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops	Vol. 3 No. 6	461
Linguet Base (Soft Lozenge)	Vol. 3 No. 6	462
Sorbitol Based Hard Lozenges	Vol. 3 No. 6	462
Sucrose Based Hard Lozenges	Vol. 3 No. 6	462
Polyethylene Glycol (PEG) Troches (Soft Lozenges)	Vol. 3 No. 6	463
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges)	Vol. 3 No. 6	463
Chewable Lozenges	Vol. 3 No. 6	464
Capsicum and Capsaicin Formulas	Vol. 3 No. 6	468
DMSO 70% Topical Solution	Vol. 3 No. 6	469
Glucosamine HCl 600-mg Capsules	Vol. 3 No. 6	470
Indomethacin 4% Topical Spray	Vol. 3 No. 6	471
Iontophoresis Solutions for Arthritis	Vol. 3 No. 6	472
Ketoprofen 2.5% in Pluronic Lecithin Organogel	Vol. 3 No. 6	473
Methotrexate 2.5-mg/5-mL Oral Liquid	Vol. 3 No. 6	474
Methyl Salicylate and Menthol Analgesic Stick	Vol. 3 No. 6	475
Piroxicam 1% Alcoholic Gel	Vol. 3 No. 6	476
Ultrasonic Preparations for Arthritis	Vol. 3 No. 6	477
Viscosity-Increasing Agents for Aqueous Systems, Featured Excipient:	Vol. 3 No. 6	479
Calculations	Vol. 3 No. 6	487
Operation of a Dry-Heat Sterilizing Oven and Validation of this Procedure	Vol. 3 No. 6	488
Calamine Lotion: Experimenting with a New Suspending Agent	Vol. 3 No. 6	490
Use of an Oxygen Extractor to Minimize Oxidation of Compounded Preparations	Vol. 3 No. 6	493
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations	Vol. 3 No. 6	496

	Mailed CD
	Instant PDF Download